Rentokil Initial plc (RTO US)
RTO US$22.79
20 minute delayed
14 days free access
Join Market Matters and get full access to all our Opinion + Action
Performance
Advanced charting functionality with the ability to amend timeframes, chart type & indicator selection, powered by TradingView.
Share price activity
Displays share price activity. Volume = number of shares traded, Turnover = value of shares traded, VWAP = volume-weighted average price for the day, sourced from Morningstar.
- Last (Price)
- 22.79
- Change
- ▼ -0.10 (-0.44)
- Bid / Ask
- 0.00 - 0.00
- Volume
- 266,118
- Turnover
- 5,405,240
- Open
- 22.81
- Day Range
- 22.60 - 22.90
- VWAP
- 22.77
- Prev Close
- 22.89
- Last Trade
- 28/10 4:10pm
Key information
Displays key information on the security, sourced from Morningstar.
- Sector
- Industrials
- Shares Issued
- 505,207,977
- NTA/Share
- -6.80
- Last Dividend
- 0.22
- Dividend Ex Date
- 14 AUG 2026
- Dividend Pay Date
- 22 SEP 2026
Current (USD) · FY2025
Displays key financial data for the most recent fiscal year, in millions. Note - Per share data is in local currency terms irrespective of reporting currency, and may be different to the stated currency, sourced from Morningstar.
- Revenue
- 6,908.00
- EBITDA
- 1,172.00
- Profit
- 470.00
- Earnings Per Share (EPS)
- 0.93
- Dividend Per Share (DPS)
- 0.41
- Yield %
- 3.02
- Market Cap
- 11,469.02
- Price to Earnings Ratio (P/E)
- 35.89
Estimates (GBP) · FY2027
Displays consensus analyst’s estimates for key measures for the next fiscal year, sourced from Morningstar.
- Revenue
- 6,120.07
- EBITDA
- 1,215.21
- Profit
- 517.15
- Earnings Per Share (EPS)
- 1.20
- Dividend Per Share (DPS)
- 0.60
Quantitative rating
Displays Morningstar’s Quantitative Equity Research Rating for the security: a star rating from 1 (overvalued) to 5 (undervalued) from the share price against a fair value estimated by a statistical model of Morningstar’s analyst ratings, with the model’s economic moat, financial health and fair value uncertainty, sourced from Morningstar.
Undervalued
- Economic Moat
- Narrow
- Financial Health
- Moderate
- Uncertainty
- Medium
Morningstar Quantitative Rating as of 21 OCT 2026.
Quantitative Equity Rating Methodology – view here
Fair value estimate
Displays Morningstar’s quantitative fair value estimate for the security against the current share price, with the band around it: the five-star price below which the model would rate the stock five stars and the one-star price above which it would rate it one star, sourced from Morningstar.
Five-star price 25.32 Fair value 28.82 One-star price 32.80
Morningstar Quantitative Rating as of 21 OCT 2026.
Quantitative valuation
Displays where the share price sits in Morningstar’s quantitative fair value band, from the five-star price (undervalued) to the one-star price (overvalued), with the fair value estimate, the price to fair value ratio, the model’s valuation label and its uncertainty rating, sourced from Morningstar.
Buy
Sell
- Fair Value
- 28.82
- Price / Fair Value
- 0.73
- Valuation
- Undervalued
- Uncertainty
- Medium
Morningstar Quantitative Rating as of 21 OCT 2026. The slider runs from the five-star price (25.32) to the one-star price (32.80).
Displays useful ratios for the security, NB the pricing date used, sourced from Morningstar.
| Ratios |
|---|
| Currency (Price/reporting): USD/USD |
| Exchange Rate: 1.0000 |
Price, volume and trading statistics for the security, sourced from Morningstar.
| Price - closing or last bid | 21.04 |
| Price - 12 month high | 34.67 |
| Price - 12 month low | 19.50 |
| Pricing date | 20 OCT 2026 |
| Volume - avg. trading volume for the last ten days | 1.60 |
| Market capitalization | 10,588.34 |
| 12 Month High price date | 14 APR 2026 |
| 12 Month Low price date | 1 OCT 2026 |
| Volume - avg. trading volume for the last 3 months | 1.79 |
| Price - 1 Day % Change | -0.80% |
| Price - 13 week price percent change | -29.89% |
| Price - 26 week price percent change | -37.27% |
| Price - 5 Day % Change | 3.95% |
| Price - 52 week price percent change | -22.13% |
| Price - YTD price percent change | -29.63% |
| Price % Change Month To Date | -1.50% |
Earnings, dividends, cash flow and book value per share, sourced from Morningstar.
| EPS excluding extraordinary items - most recent fiscal year | 0.572 |
| EPS excluding extraordinary items - trailing 12 month | 0.635 |
| EPS Normalized - most recent fiscal year | 1.290 |
| Revenue/share - most recent fiscal year | 13.625 |
| Revenue/share - trailing 12 month | 14.058 |
| Book value per share - most recent fiscal year | 10.921 |
| Book value per share - most recent quarter | 10.961 |
| Book value (tangible) per share - most recent fiscal year | -6.802 |
| Book value (tangible) per share - most recent quarter | -6.643 |
| Cash per share - most recent fiscal year | 4.608 |
| Cash per share - most recent quarter | 4.910 |
| Cash Flow per share - most recent fiscal year | 1.791 |
| Cash Flow per share - trailing 12 month | 1.774 |
| Dividend per share - most recent fiscal year | 0.412 |
| Dividends per share - trailing 12 month | 0.636 |
| EBITD per share - trailing 12 month | 2.395 |
| EPS Basic excluding extraordinary items - most recent fiscal year | 0.575 |
| EPS Basic excluding extraordinary items - trailing 12 month | 0.638 |
| EPS including extraordinary items - most recent fiscal year | 0.931 |
| EPS including extraordinary items - trailing 12 month | 0.947 |
| Free Cash Flow per share - trailing 12 month | 1.334 |
Valuation multiples such as P/E, price to sales, price to book and enterprise value ratios, sourced from Morningstar.
| P/E excluding extraordinary items, most recent fiscal year | 33.13 |
| P/E Normalized, most recent fiscal year | 15.68 |
| Price to sales - most recent fiscal year | 1.50 |
| Price to Tangible Book - most fiscal year | — |
| Price to Free Cash Flow per Share - most recent fiscal year | 15.77 |
| Price to Cash Flow per share - trailing 12 month | 11.86 |
| Price to Book - most recent fiscal year | 1.92 |
| P/E excluding extraordinary items high, trailing 12 months | 60.35 |
| P/E excluding extraordinary items low, trailing 12 months | 31.10 |
| Net Debt, LFI | 3,617.00 |
| Net Debt, LFY | 3,809.00 |
| Dividend Yield - 5 Year Average | 1.70% |
| Dividend Yield - indicated annual dividend divided by closing price | 3.00% |
| Current Dividend Yield - Common Stock Primary Issue, LTM | 3.02% |
Cash flow, liquidity and leverage measures, sourced from Morningstar.
| Free Cash Flow - most recent fiscal year | 639.00 |
| LT debt/equity - most recent fiscal year | 82.78% |
| Payout ratio - most recent fiscal year | 44.44% |
| Total debt/total equity - most recent fiscal year | 111.58% |
| LT debt/equity - most recent quarter | 72.18% |
| Total debt/total equity - most recent quarter | 110.41% |
| Free Cash Flow - trailing 12 month | 677.00 |
| Payout ratio - trailing 12 month | 45.44% |
Key income statement lines for the most recent fiscal year, in millions, sourced from Morningstar.
| Revenue - most recent fiscal year | 6,908.00 |
| Revenue - trailing 12 month | 7,133.00 |
| EBITD - most recent fiscal year | 1,172.00 |
| EBITD - trailing 12 month | 1,215.00 |
| Earnings before taxes - most recent fiscal year | 390.00 |
| Earnings before taxes - trailing 12 month | 437.00 |
| Net Income available to common - most recent fiscal year | 470.00 |
| Net Income available to common - trailing 12 months | 478.00 |
| Earnings before taxes Normalized - most recent fiscal year | 459.00 |
| Net Income Available to Common, Normalized - most recent fiscal year | 654.00 |
| Earnings per Share, Normalized, Excluding Extraordinary Items, Avg. Diluted Shares Outstanding, TTM | 1.34 |
Profitability margins for the most recent fiscal year, sourced from Morningstar.
| Net Profit Margin % - 1st historical fiscal year | 4.20% |
| Net Profit Margin % - trailing 12 month | 4.51% |
| Operating margin - 1st historical fiscal year | 9.53% |
| Operating margin - trailing 12 month | 9.90% |
| Pretax margin - trailing 12 month | 6.13% |
| Pretax margin - 1st historical fiscal year | 5.65% |
| Operating Margin - 5 year average | 10.82% |
| Pretax Margin - 5 year average | 8.09% |
| Free Operating Cash Flow/Revenue, 5 Year Average | 11.52% |
| Free Operating Cash Flow/Revenue, TTM | 9.49% |
| Net Profit Margin - 5 year average | 6.28% |
Returns on average assets and equity for the fiscal year, the trailing 12 months and as 5 year averages, and net income and revenue per employee in whole currency, sourced from Morningstar.
| Return on average assets - most recent fiscal year | 2.08% |
| Return on average assets - trailing 12 month | 2.24% |
| Return on average equity - most recent fiscal year | 5.42% |
| Return on average equity - trailing 12 month | 5.93% |
| Return on average assets - 5 year average | 3.14% |
| Return on average equity - 5 year average | 10.35% |
| Net Income/employee - most recent fiscal year | 4,525.31 |
| Revenue/employee - most recent fiscal year | 107,796.02 |
Growth in revenue, earnings, dividends and book value over recent periods, sourced from Morningstar.
| Revenue growth rate, 5 year | 13.97% |
| EPS growth rate, 5 year | 7.70% |
| Growth rate% - dividend, 3 year | 13.94% |
| Revenue/share (5 yr growth) | 7.16% |
| Growth rate% - Revenue, 3 year | 14.70% |
| Growth rate% - EPS, 3 year | 9.33% |
| Book value per share growth rate, 5 year | 21.34% |
| Capital Spending growth rate, 5 year | 6.52% |
| Earnings Before Interest, Taxes, Depreciation & Amortization, 5 Year CAGR | 9.72% |
Displays analyst’s forecasts for key measures. The estimates can be expanded to see the spread of the calls. Full lines = reported, and dotted lines are forward estimates. Click a measure to add or remove it from the chart, sourced from Morningstar.
Financial forecast (GBP, millions except per share)
| Actuals | Estimates | |||||||
| 2025 | 2026 | 2027 | 2028 | 2029 | ||||
| Estimate breakdown | ||||||||
Financial metrics can be plotted on the graph to see trends. Multiple metrics from multiple statements can be plotted against each other, sourced from Morningstar.
Financials (USD, millions)
| Period end: | DEC 21 | DEC 22 | DEC 23 | DEC 24 | DEC 25 |
| Fiscal year: | 2021 | 2022 | 2023 | 2024 | 2025 |
| Period length: | 12 months | 12 months | 12 months | 12 months | 12 months |
Displays all company announcements released by the company to the exchange, sourced from Morningstar.
Announcements
Announcements are available for ASX-listed companies only.
Opinion
No opinions for this company yet.
Action
No actions for this company yet.
Business Summary
Rentokil Initial is the largest global provider of route-based pest control and commercial hygiene services, operating in over 90 countries, with its largest operations in the United States following the acquisition of Terminix. The group also offers a range of specialist route-based services, including office and commercial space plant care, property care, and workwear rentals. The group serves a diverse client base of global food producers, hotel chains, industrial goods companies, restaurants, and individual residential customers.
Relevant suggested news and content from the site
Video
WATCH
Webinar Recording: Are commodities entering a Supercycle?
Recorded Wednesday 24th June @ 12.30pm
Podcast
LISTEN
Thursday 11th September – Dow off -220pts, SPI off -20pts
Daily Podcast Direct from the Desk
Video
WATCH
Buy Hold Sell: The 6 income stocks readers love, plus 2 expert ideas
Recorded 10th June 2026
Podcast
LISTEN
Wednesday 10th September – Dow up +196pts, SPI down -4pts
Daily Podcast Direct from the Desk
